PALO ALTO, Calif.--(BUSINESS WIRE)--Vascular Closure Systems, Inc. is pleased to announce that it has recently secured initial corporate funding. The proceeds from the funding will be used to accelerate the development of the company’s core technology and to support regulatory activities. The company’s technology is based on several issued and pending patents, and has been engineered to be easier to learn, easier to use and more cost effective than current vascular closure systems. Versions of our system include bioabsorbable, removable/temporary use and permanent sealing element designs. Our system does not require a second device (deployment or infusion) to be inserted/reinserted into the puncture site. Additionally, the closure system may be packaged already loaded onto a vascular introducer, catheter, guide catheter, guide wire, etc.
